MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer.
about
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseasesPaclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation TherapyCIViC databaseTumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerbba, a synthetic derivative of 23-hydroxybutulinic acid, reverses multidrug resistance by inhibiting the efflux activity of MRP7 (ABCC10)Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs.Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Abcc10 status affects mammary tumour growth, metastasis, and docetaxel treatment responseReversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar.Contribution of Abcc10 (Mrp7) to in vivo paclitaxel resistance as assessed in Abcc10(-/-) mice.Significance of c-MET overexpression in cytotoxic anticancer drug-resistant small-cell lung cancer cellsmiR-17-5p downregulation contributes to paclitaxel resistance of lung cancer cells through altering beclin1 expressionSrc family kinases and paclitaxel sensitivity.The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study.The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancerPDE5 inhibitors, sildenafil and vardenafil, reverse multidrug resistance by inhibiting the efflux function of multidrug resistance protein 7 (ATP-binding Cassette C10) transporterDisturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer.Modulation of the ATPase and transport activities of broad-acting multidrug resistance factor ABCC10 (MRP7).miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivoMicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms.Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B.Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma.FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.Multidrug resistance associated proteins in multidrug resistance.Priming cancer cells for drug resistance: role of the fibroblast niche.Early assessment of tumor response to JAC106, an anti-tubulin agent, by 3'-deoxy-3'-[¹⁸F]fluorothymidine in preclinical tumor models.Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells.Chemotherapy Resistance in Lung Cancer.The role of the SHH gene in prostate cancer cell resistance to paclitaxel.Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma.miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A.
P2860
Q24601963-5CEEF00F-BDB7-4116-9EC9-0EE4AC8F2587Q26775004-6DFAA9DF-00A1-4271-B69D-1B0634EE6B31Q27612411-E3DFCCFB-E191-4E51-B465-93883C4D76E6Q28396304-D44F4A0C-235C-4742-9B6F-E8659E44624DQ28533538-6E6A7826-BB8F-4083-A298-38EDE08E35B9Q33633267-592A46D1-69D8-454E-AAE9-9FB3F42F6250Q33714593-5D54403D-9CC6-45E3-99AD-6E8BD826F412Q34051930-A1724461-736B-402C-9CD7-80E20C1E7CEFQ34581006-BAEABE7B-9195-44B6-9B81-204E10C51477Q34988593-3824FD73-42F1-446C-B127-684F38065F9CQ35051630-94B01B67-C739-4BB6-A088-16412062E239Q35154831-CE118232-0619-4A41-9E77-0C5849A96207Q35214722-99CB2448-8281-4BA6-9ED4-4FEA0807AEE1Q35238509-7BD57E3F-1FC4-491F-A309-4723B097FF3DQ35813690-BB2C7F10-B2AE-496A-A74E-2BBBA13194D7Q36124056-32717024-4568-4D3A-86ED-B634C82E2277Q36290193-45A3D5CC-9231-42D8-A994-581879008C26Q36476289-36FBBC7F-3976-4CB9-9C18-9A7D087A4494Q36610611-97CED217-7122-4309-81E6-F4F78DD69124Q37269100-D2EEAA18-5C44-48AA-AA30-F4C55BE6ECC4Q37306809-DA5D0CB3-38C0-4DED-9400-EF8C551AF59BQ37351193-8C0D68B8-BF85-4574-B297-EA5BC88000D0Q37634419-92916AE9-D861-4BC6-8DC3-572A630BAC34Q37702756-F1E0F2DD-4FFC-4DDC-9142-BE6CBFB7464FQ37958163-14F42D05-2155-4938-89A9-251D217F7B6CQ38232067-68FAC04D-7A25-4016-BCCA-46BCA73B87E5Q38475122-35B193C5-4DA7-4E05-B9B3-C1EC120548F4Q38618124-907C3A06-70F8-4A58-BF11-687B06F91BB2Q38669287-0619484F-0D58-4DA4-A600-B3D34F9EB2C4Q38985293-D4A089E5-7231-4B47-9C23-E56275484BD8Q39663607-DBBB8F6E-F27C-4F8A-87F2-FEB323F660C4Q54516791-60C958B9-214F-4AAC-B19D-BEDDCC518571
P2860
MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
MRP7/ABCC10 expression is a pr ...... in non-small cell lung cancer.
@ast
MRP7/ABCC10 expression is a pr ...... in non-small cell lung cancer.
@en
MRP7/ABCC10 expression is a pr ...... in non-small cell lung cancer.
@nl
type
label
MRP7/ABCC10 expression is a pr ...... in non-small cell lung cancer.
@ast
MRP7/ABCC10 expression is a pr ...... in non-small cell lung cancer.
@en
MRP7/ABCC10 expression is a pr ...... in non-small cell lung cancer.
@nl
prefLabel
MRP7/ABCC10 expression is a pr ...... in non-small cell lung cancer.
@ast
MRP7/ABCC10 expression is a pr ...... in non-small cell lung cancer.
@en
MRP7/ABCC10 expression is a pr ...... in non-small cell lung cancer.
@nl
P2093
P1476
MRP7/ABCC10 expression is a pr ...... in non-small cell lung cancer.
@en
P2093
Hiroaki Ozasa
Hiroyoshi Maeda
Mikinori Miyazaki
Ryuzo Ueda
Shigeki Sato
Takehiro Uemura
Tetsuya Oguri
Yuji Bessho
P304
P356
10.1158/1535-7163.MCT-07-2088
P577
2008-05-01T00:00:00Z